Dr. Nicholas Hanser

Dr. Nicholas Hanser joined Saxenhammer as Partner and Head of Technology Investment Banking in 2019. His team focuses on Software, Digital Healthcare, Tech-enabled services, FinTech and the broader Technology sector.

Nicholas brings over 16 years of international Corporate Finance and Investment Banking experience with organizations such as Credit Suisse First Boston, Jefferies, BNP Paribas, and Bryan Garnier based in Zurich, London, Frankfurt, and Munich.

During his career he was involved in more than 60 transactions and closed more than € 35 bn. of deal volume across different industry verticals with a focus on the Technology and Healthcare space. He has a global network in the investor and acquirer community and closed successful deals with companies such as Hellman & Friedman, Blackstone, Scout24, Deutsche Post DHL, Elis, Manz, Zealand Pharma, Nordex, Aixtron, Refresco Gerber, Seplat Petroleum, Sixt Leasing, Telefonica, tado, HABYT, NexWafe and MorphoSys. He is also a private start-up investor as well as board member of various companies in the Technology sector.

As a Partner and Head of Technology Investment Banking he leads our Global Technology Investment Banking team and is part of the CDI Global sector teams for Technology and Healthcare.

Nicholas holds a PhD in Economics and Management and a Masters in Management from ESCP Business School, as well as a Master of Science from Bayes Business School (formerly known as Cass Business School) in London.